Everolimus 0.75 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3UBR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,278
Award facts
- Contract value 100% obligated
- $16,278.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 21, 2026, for the supply of Everolimus 0.75 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $16,278.18, was issued without set-aside designation and is scheduled for completion by January 22, 2026. The work will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerSourceBergen Drug Corp functions as a critical vendor within the federal pharmaceutical supply chain, delivering a broad portfolio of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Everolimus, an immunosuppressant and anticancer medication, represents a specialty pharmaceutical commodity consistent with the company's demonstrated capability to fulfill federal procurement requirements across multiple therapeutic domains. The non-set-aside competitive award reflects AmerSourceBergen's proven ability to meet federal medical supply standards through open competition and reinforces its position as a primary pharmaceutical distributor for military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F3UBR?
SPE2DR26F3UBR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F3UBR worth?
The government has obligated $16,278 on SPE2DR26F3UBR.
Is contract SPE2DR26F3UBR an order under another contract?
Yes. SPE2DR26F3UBR is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UBR competed?
The extent of competition for SPE2DR26F3UBR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award